enVVeno Medical Corporation (NVNO) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
애널리스트 추정 주당순이익(EPS) $-46.20 및 매출 $0.00B 다음 회계연도.
주당순이익(EPS) 실적 추이: 2024: 실적 $-1.27 vs 추정 $-46.20 (상회 +97.3%). 2025: 실적 $-33.06 vs 추정 $-37.80 (상회 +12.5%). 애널리스트 정확도: 0%.
